1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
- 2017
- NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
- Rare variant, gene-based association study of hereditary melanoma using whole-exome sequencing
- 2016
- High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma
- Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
- Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
- Promoter Methylation of PTEN is a Significant Prognostic Factor in Melanoma Survival.
- An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.